Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man

References

• ARIAS, I. M., 1988, In I. M. Arias, W. B. Jakoby, H. Popper, D. Scahacter and D. A. Shafritz (eds), The Liver: Biology and Pathobiology (New York: Raven), pp. 3–10.
   Google Scholar
• ASHFORTH, E. L., CARLILE, D. J., CHENERY, R. J. and HOUSTON, J. B., 1995, Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data. Journal of Pharmacology and Experimental Therapeutics, 274, 761–766.
   PubMed Web of Science ®Google Scholar
• BAYLISS, M. K., BELL, J. A., WILSON, K. and PARK, G. R., 1994, 7-Ethoxycoumarin 0-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions. Xenobiotica, 24, 231–241.
   PubMed Web of Science ®Google Scholar
• BELL, J. A., BRADBURY, A., JENNER, W. N., MANCHEE, G. R. and MARTIN, L. E., 1983, The metabolism of loxtidine in rat and dog. Biochemical Society Transactions, 11, 715–716.
   Google Scholar
• BEGUE, J. M., LE BIGOT, J. F., GUGUEN-GUILLOUZ0, C., KIECHEL, J. R. and GuILLouzo, A., 1983, Cultured human hepatocytes: a new model for drug metabolism studies. Biochemical Phar-macology, 32, 1643–1646.
   Google Scholar
• BRITTAIN, R. T. and JACK, D., 1983, Histamine 1-1,-antagonists — past, present and future. Journal of Clinical Gastroenterology, 5, 71–79.
   PubMed Web of Science ®Google Scholar
• BOXENBAUM, H., 1980, Interspecies variation in liver weight, hepatic blood flow and antipyrene clearance: extrapolation of data to benzodiazepines and phenytoin. Journal of Pharmacokinetics and Biopharmaceutics, 8, 165–176.
   PubMedGoogle Scholar
• CARLILE, D. J., ZOMORODI, K. and HOUSTON, J. B., 1997, Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes and intact liver. Drug Metabolism and Disposition, 25, 903–911.
   PubMed Web of Science ®Google Scholar
• CHENERY, R. J., 1988, The utility of hepatocytes in drug metabolism studies. In G. G. Gibson (ed.), Progress in Drug Metabolism, vol. 11 (London: Taylor & Francis), pp. 217–265.
   Google Scholar
• CHENERY, R. J., AYRTON, A., OLDHAM, H. G., STANDRING, P., SEDDON, T. and KIRBY, R., 1987, Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog guinea pig and man. Drug Metabolism and Disposition, 15, 312–317.
   PubMed Web of Science ®Google Scholar
• EKINS, S., WILLIAMS, J. A., MURRAY, G. I., BURICE, M. D., MARCHANT, N. C., ENGESET, J. and HAWKSWORTH, G. M., 1996, Xenobiotic metabolism in rat, dog and human precision cut liver slices, freshly isolated hepatocytes and vitrified precision cut liver slices. Drug Metabolism and Disposition, 24, 990–995.
   PubMed Web of Science ®Google Scholar
• FABRE, G., COMBALBERT J., BERGER, Y. and CANO, J.-P., 1990, Human hepatocytes as a key in vitro model to improve pre clinical drug development. European Journal of Drug Metabolism and Pharmacokinetics, 15, 165–171.
   Google Scholar
• GREEN, C. E., LE VALLEY, S. E. and TYSON, C. A., 1986, Comparison of amphetamine metabolism using isolated hepatocytes from five species including human. Journal of Pharmacology and Experimental Therapeutics, 237, 931–936.
   PubMed Web of Science ®Google Scholar
• GuILLouzo, A., BEGUE, J.-M., MAURER, G. and KOCH, P., 1988, Identification of metabolic pathways of pindolol and fluperlapine in adult human hepatocyte cultures. Xenobiotica, 18, 131–139. HARRISON, C., JENNER W. N., MARTIN, L. E. and YOUNG, S. N., 1983, Radioimmunoassay of loxtidine and lamtidine. Biochemical Society Transactions, 11, 713–714.
   Google Scholar
• HAS, K. A., BRENNAN, B., CHENERY, R. J. and HOUSTON, J. B., 1995, In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data. Drug Metabolism and Disposition, 23, 349–353.
   PubMed Web of Science ®Google Scholar
• HOUSTON, J. B., 1994, Commentary. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochemical Pharmacology, 47, 1469–1479.
   PubMed Web of Science ®Google Scholar
• HOUSTON, J. B. and CARLILE, D. J., 1997, Incorporation of in vitro drug metabolism data into physiologically based pharmacokinetic models. Toxicology in Vitro, 11, 473–478.
   PubMed Web of Science ®Google Scholar
• HUMPEL, M., SOSTAREK, D., GlESCHEN, H. and LABITZKY, C., 1989, Studies On the biotransformafion of ionazolac, bromerguride, lisuride and terguride in laboratory animals and their hepatocytes. Xenobiotica, 19, 361–377.
   PubMed Web of Science ®Google Scholar
• INABA, T., UMEDA, T., MAHON, W. A., Ho, J. and JEEJEEBHOY, K. N., 1975, Isolated rat hepaotcytes as a model to study drug metabolism: dose-dependent metabolism of diphenylhydantoin. Life Sciences, 16, 1227–1232.
   PubMed Web of Science ®Google Scholar
• IWATSUBO, T., HIROTA, N., 001E T, SUZUKI, H., SHIMADA, N., CHIBA, K., ISHIZAKI, T., GREEN, C. E., TYSON C. A. and S UGIYAMA, Y., 1997a, Prediction of in vivo metabolism in the human liver from in vitro metabolism data. Pharmacology Therapeutics, 73, 147–171.
   Google Scholar
• IWATSUBO, T., SUZUKI, H., SHIMADA, N., CHIBA, K., ISHIZAKI, T., GREEN, C. E., TYSON, C. A., Yoxoi, T., KAMATAKI T and SUGIYAMA, Y., 1997b, Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes. Journal of Pharmacology and Experimental Therapeutics, 282, 909–919.
   Google Scholar
• JAJoo, J. K., BLAIR, I. A., KLuNx, L. J. and MAYOL, R. F., 1990, In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo. Xenobiotica, 20, 779–786.
   PubMed Web of Science ®Google Scholar
• JAuREoui, H. 0., HAYNER, N. T., DRISCOLL, J. L., WILLIAMS -HOLLAND, R., LIPSKY, M. H. and GALLETTI, P. M., 1981, Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes — freshly isolated cells, cell suspension, and primary monolayer cultures. In Vitro, 17, 1100–1111.
   Google Scholar
• JENNER W. N., BROWN, I. L., BRADBURY, A. and MANCHEE, G. R., 1984, The metabolism of loxtidine in man (unpublished).
   Google Scholar
• LABAUNE, J.-P., 1989, Interpretation of kinetic data. In M. H. Rubenstein (ed.), Handbook of Pharmacokinetics: Toxicity Assessment of Chemicals (Chichester: Ellis Horwood), pp. 293–499.
   Google Scholar
• LACARELLE, B., MARRE, F., DURAND, A., DAVI, H. and RAHMANI, R., 1991, Metabolism of minaprine in human and animal hepatocytes and liver microsomes — prediction of metabolism in vivo. Xenobiotica, 21, 317–329.
   PubMed Web of Science ®Google Scholar
• LAVE, T., COASSOLO, P., UBEAUD, G., BRANDT, B. B. R., SCHMITT, C., DUPIN, S., JAECK, D. and CHOU, R. C., 1996b, Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling. Pharmaceutical Research, 13, 97–101.
   Google Scholar
• LAVE, T., DUPIN, S., SCHMITT, M., KAPPS M., MEYER, J., MORGENROTH, B., CHOU, R. C., JAEcx, D. and COASSOLO, P., 1996a, Interspecies scaling of tolcapone, a new inhibitor of catechol-0-methyltransferase. Use of in vitro data from hepatocytes to predict metabolic clearance in animals and humans. Xenobiotica, 26, 839–851.
   Google Scholar
• LAVE, T., DUPIN, S., SCHMITT, C., VALLES B., UBEAUD, G., CHOU, R., JAEcx, D. and COASSOLO, P., 1997, The use of hepatocytes to select compounds based on their expected hepatic extraction ratios in humans. Pharmaceutical Research, 14, 152–155.
   Google Scholar
• LAVE, T., SCHMITT -HOFFMANN, A. H., COASSOLO, P., VALLES B., UBEAUD, G., BRANDT, B. B. R. and CHOU, R. C., 1995,A new extrapolation method from animals to man: application to a metabolised compound, mofarotene. Life Sciences, 56, 473–478.
   Google Scholar
• LAVRUSEN, K., VAN HOUDT J., VAN DYCK, D., HENDRICKX J., BOCKX, M., HURKMANS, R., MEULDERMANS, W., LE JEUNE, L., LAvwERs, W. and HEYKANTS J.,1992, Comparative metabolism of flunarizine in rats, dogs and man: an in vitro study with subcellular liver fractions and isolated hepatocytes. Xenobiotica, 22, 815–816.
   Google Scholar
• LE BIGOT, J. F., BEGUE, J. M., KlECHEL, J. R. and GUILLOUZO, A., 1987, Species differences in metabolism of ketotifen in rat, rabbit and man: demonstration of similar pathways in vivo and in cultured hepatocytes. Life Sciences, 40, 883–890.
   PubMed Web of Science ®Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin-Phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• McCoRmicx, D. J., FITZGERALD, T. C. and McKILL0E, D., 1988, The metabolism of propranolol (InderalTM) and xamoterol (CorwinTM) by isolated rat hepatocytes: in vivo-in vitro correlations. Xenobiotica, 18, 1401–1412.
   Google Scholar
• MIZUMA, T., MACHIDA, M., HAYASHI, M. and AWAZU, S., 1982, Correlation of drug conjugative metabolism rates between in vivo and in vitro: glucuronidation and sulphation ofp-nitrophenol as a model compound. Journal of Pharmacobiodynamics, 5, 811–817.
   PubMedGoogle Scholar
• MORGAN, D. J. and SMALLWOOD, R. A., 1990, Clinical significance of pharmacokinetics : models of hepatic elimination. Clinical Pharmacokinetics, 18, 61–76.
   PubMed Web of Science ®Google Scholar
• OLDHAM, H. G., CHENERY, R. J., STANDRING, P., NORMAN, S. J., GARTON, A. and AYRTON, A. D., 1986, Drug metabolism kinetic studies in a hepatocyte model. Food and Chemical Toxicology, 24, 761–762.
   Web of Science ®Google Scholar
• OLDHAM, H. G., NORMAN, S. J. and CHENERY, R. J., 1985, Primary cultures of adult rat hepatocytes — a model for the toxicity of histamine H,-receptor antagonists. Toxicology, 36, 215–229.
   PubMed Web of Science ®Google Scholar
• OLDHAM, H. G., STANDRING, P., NORMAN, S. J., BLAKE, T. J., BEATTIE, I., Cox, P. J. and CHENERY, R. J., 1990, Metabolism of temelastine (SKF93944) in hepatocytes from rat, dog, cynomolgus monkey and man. Drug Metabolism and Disposition, 18, 146–152.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964a, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964b, The carbon monoxide binding pigment of liver microsomes. II.
   Google Scholar
• Solubilisation, purification and properties. Journal of Biological Chemistry, 239, 2379–2385. O'NEILL, R., 1971, Function minimisation using a simplex procedure. Journal Royal Statistical Society C, 20, 338–345.
   Google Scholar
• PAHERNIK, S. A., SMIHMID J., SAUTER, T., ScHIDBERo, F. W. and KOEBE, H. G., 1995, Metabolism of pimobendan in long term human hepatocyte culture: in vivo-in vitro comparison. Xenobiotica, 25, 811–823.
   Google Scholar
• PANG, K. S., KONG, P., TERRELL, J. A. and BILLINGS, R. E., 1985, Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. Drug Metabolism and Disposition, 13, 42–50.
   PubMed Web of Science ®Google Scholar
• SANDKER, G. W., Vos, R. M. E., DELBRESSINE, L. P. C., SLOOP, M. J. H., MEIJER, D. K. F. and GROOTHUIS, G. M. M., 1994. Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo. Xenobiotica, 24, 143–155.
   Google Scholar
• SANWALD -DUCRAY, P. and Dow, J., 1997, Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling. Xenobiotica, 27, 189–201.
   PubMed Web of Science ®Google Scholar
• SEDDON, T., MICHELLE, I. and CHENERY, R. J., 1989, Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog. Biochemical Pharmacology, 38, 1657–1665.
   PubMed Web of Science ®Google Scholar
• SINGH, K., TRIPP, S. L., DUNTON, A. W., DOUGLAS, F. L. and RAKHIT, A., 1991, Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes. Drug Metabolism and Disposition, 19, 990–995.
   PubMed Web of Science ®Google Scholar
• TSURU, M., ERICKSON, R. R. and HOLTZMAN, J. L., 1982, The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats. Journal of Pharmacology and Experimental Therapeutics, 222, 658–661.
   PubMed Web of Science ®Google Scholar
• WARNER, M., LA MARCA, M. V. and NMS, A. H., 1978, Chromatographic and electrophoretic heterogeneity of the cytochromes P450 solubilised from untreated rat liver. Drug Metabolism and Disposition, 6, 353–362.
   PubMed Web of Science ®Google Scholar
• WATKINS, J. B. and KLAASSEN, C. D., 1983, Chemically induced alteration of UDP-glucuronic acid concentration in rat liver. Drug Metabolism and Disposition, 11, 37–40.
   PubMed Web of Science ®Google Scholar
• ZOMORODI, K., CARLILE, D. J. and HOUSTON, J. B., 1995, Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance. Xenobiotica, 25, 907–916.
   PubMed Web of Science ®Google Scholar